Axonics Modulation Technologies, Inc.

Axonics, Inc.

Avery Dennison Corporation

Jabra Corporation

Hitachi Global Storage Technologies Netherlands B.v.

Discus Dental, LLC

The Gillette Company

Insleep Technologies, LLC

The Procter Gamble Company

Rubbermaid Office Products

Boston Scientific Scimed, Inc.

Microcomputer Accessories Incorporated

Encad, Inc.

Belkin Components

Mad Catz, Inc.

Dennis Lynn Schroeder

Stuart Karten

John Woock

Eric V Schmid

Guangqiang Jiang

Stuart Allan Karten

Paul Trotman Kirley

Prabodh Mathur

Eric W Olson

Ronaldo Fernandez Carreon

Medford Alan Dyer

Thomas Henry Perszyk

Simon Andre Sollberger

John Lynn Harting

Christopher LaBrutto

Andy Jason Logan

Lester Clifford Anderson

Tony Cowley

Reaz Rahman

Christian Denhart

Kathleen Ann Baker

Eric Paul Rose

Douglas H Grambush

Robert Hayman

Kenneth Lawrence Rosenblood

Dac V Vu

Janelle Yurong Wang Treadway

Younes Shabany

James MacDonald Turnbull

Anita Habeich

Christopher N Quan

Andres Dandler

Curt Deckert

Tracy Taylor Haugh

H Charles Hassel

Norman Curtis Yamamoto

Jonathan Abarbanel

Wayne D Robens

Bruce Alan Sargeant

Arthur G Castillo

Michael J Rocha

Cezanne Farris-Gilbert

Glen Arthur Noda

Eric Olson

Rinda Sama

Raymond W Cohen

Lillian Norton

Jeffrey Walter Benzler

Jeffrey Walter Bentzler

Nancy N Quan

Steve Piorek

Michael H Gusky

Robert Blumenfeld

Marc Orloff

Christopher Lee Clark

Donald Carpenter Stiff

Madeline Derby

William Dorfman

Eric Schmid

Brian Kennedy

Guanqiang Jiang

Martin W Kerber

Simon A Sollberger

Martin Baecke

Nathaniel V Tran

Marcel Borgward

Uwe Schwerdtfeger

Robert Fey

Donald W Finkle

William M Moselle

James MacDonal Turnbull

Kam Leung

Duane Lee

Steven Chance Elliot

Chris Clark

Bernard Lo

Erin Williams

Cynthia Kossayan

Guangqing Jiang

Greg Miller

Jiang Guangqiang

Ken Rosenblood

Stuart Hagen

Curt Kenneth Deckert

Systems and methods for providing a trial neurostimulation to a patient for assessing suitability of a permanently implanted neurostimulation are provided herein. In one aspect, a trial neurostimulation system includes an EPG affixation device that secures the EPG to the patient when connected to a lead extending through a percutaneous incision to a target tissue location, while allowing for ready removal of the EPG for charging or bathing. In another aspect, the system includes an EPG provided with a multi-purpose connector receptacle through which the EPG can deliver neurostimulation therapy to an implanted lead or the EPG can be charged. In yet another aspect, the EPG can include a multi-purpose connector receptacle that is alternatingly connectable with a plurality of differing connector to facilitate differing types of therapies with one or more neurostimulation devices, ground patches or various other devices, such as charging or testing devices.

External pulse generator device and affixation device for trial nerve stimulation and methods of use

Charger holder

Methods and systems for obtaining and analyzing electromyography responses of electrodes of an implanted neurostimulation lead for use neurostimulation programming are provided herein. System setups for neural localization and/or programming include a clinician programmer coupleable with a temporary or permanent lead implantable in a patient and at least one pair of EMG sensing electrodes minimally invasively positioned on a skin surface or within the patient. The clinician programmer is configured to determine a plurality of recommended electrode configurations based on thresholds and EMG responses of the plurality of electrodes and rank the electrode configuration according to pre-determined criteria. The clinician programmer further includes graphical user interface on which the plurality of recommended electrode configurations are displayed for modification and/or selection by a clinician in programming an IPG or EPG coupled with the lead to apply a neurostimulation treatment according to the selected electrode configuration.

Methods for determining neurostimulation electrode configurations based on neural localization

The present invention provides improved methods for positioning of an implantable lead in a patient with an integrated EMG and stimulation clinician programmer. The integrated clinician programmer is coupled to the implantable lead, wherein the implantable lead comprises at least four electrodes, and to at least one EMG sensing electrode minimally invasively positioned on a skin surface or within the patient. The method comprises delivering a test stimulation at a stimulation amplitude level from the integrated clinician programmer to a nerve tissue of the patient with a principal electrode of the implantable lead. Test stimulations are delivered at a same stimulation amplitude level for a same period of time sequentially to each of the four electrodes of the implantable lead. A stimulation-induced EMG motor response is recorded with the integrated clinician programmer for each test stimulation on each electrode of the implantable lead via the at least one pair of EMG sensing electrodes so as to facilitate initial positioning of the implantable lead at a target stimulation region.

Electromyographic lead positioning and stimulation titration in a nerve stimulation system for treatment of overactive bladder

Methods for transcutaneous charging of an implanted device may include removably coupling a charging device with a carrier having adhesive tabs, the tabs being movable between a first position configured to be spaced away from a skin surface and a second position configured to be urged against the skin surface; engaging a bottom surface of the charging device at least partially against the skin surface with the tabs in the first position; positioning the charging device until it is at least partially positioned over or proximate the implanted medical device; and moving the tabs to the second position so that respective adhesive surfaces of the tabs contact and adhere to the skin of the patient sufficiently to support the charging device coupled with the carrier for a duration of time sufficient to charge the implanted device.

Attachment devices and associated methods of use with a nerve stimulation charging device

Systems and methods for providing a trial neurostimulation to a patient for assesssing suitability of a permanently implanted neurostimulation are provided herein. In one aspect, a trial neurostimulation system includes an EPG patch adhered to a skin surface of a patient and connected to a lead extending through a percutaneous incision to a target tissue location. The EPG may be a modified version of the IPG used in the permanent system, the EPG may be smaller and/or lighter than the corresponding IPG device. The EPG and a lead extension may be sealed to allow improved patient mobility and reduced risk of infection. The EPG may be compatible with wireless systems used to control and monitor the IPG such that operation and control of the EPG is substantially the same in each system to allow seemless conversion to the permanently implanted system.

External pulse generator device and associated methods for trial nerve stimulation

Implantable pulse generator external charger

Systems and methods for providing a trial neurostimulation to a patient for assessing suitability of a permanently implanted neurostimulation are provided herein. In one aspect, a trial neurostimulation system includes an EPG affixation device that secures the EPG to the patient when connected to a lead extending through a percutaneous incision to a target tissue location, while allowing for ready removal of the EPG for charging or bathing. In another aspect, the system includes an EPG provided with a multi-purpose connector receptacle through which the the EPG can deliver neurostimulation therapy to an implanted lead or the EPG can be charged. In yet another aspect, the EPG can include a multi-purpose connector receptacle that is alternatingly connectable with a plurality of differing connector to facilitate differing types of therapies with one or more neurostimulation devices, ground patches or various other devices, such as charging or testing devices.

A neurostimulation system having an external or an implantable pulse generator programmed to innervate a specific nerve or group of nerves in a patient through an electrode as a mode of treatment, having a patient remote that wirelessly communicates with the pulse generator to increase stimulation, decrease stimulation, and provide indications to a patient regarding the status of the neurostimulation system. The patient remote can allow for adjustment of stimulation power within a clinically effective range and for turning on and turning off the pulse generator. The patient remote and neurostimulation system can also store a stimulation level when the pulse generator is turned off and automatically restore the pulse generator to the stored stimulation level when the pulse generator is turned on.

Patient remote and associated methods of use with a nerve stimulation system

A clinician programmer may be coupled with an implantable temporary or permanent lead in a patient. Generally, the clinician programmer may comprise a portable housing, a signal/stimulation generator, and a graphical user interface. The housing has an external surface and encloses circuitry at least partially disposed within the housing. The signal/stimulation generator may be disposed within the housing and configured to deliver test stimulation to a nerve tissue of the patient via the implantable lead. The graphical user interface at least partially comprises the external surface of the housing and has a touch screen display for direct user interaction or for use with a keyboard, mouse, or the like.

Clinician programmer for use with an implantable neurostimulation lead

Patient remote

Growing community of inventors

Los Angeles, CA, United States of America

Dennis Lynn Schroeder